Source: Reuters

External Affairs Minister S Jaishankar held another round of "productive interaction" with his UAE counterpart Sheikh Abdullah bin Zayed Al Nahyan here where the two leaders discussed the entire gamut of bilateral relations, especially the strong focus on economic recovery post COVID-19.

Jaishankar arrived in Abu Dhabi on Sunday with a focus on boosting bilateral economic cooperation. His visit to the United Arab Emirates comes amid evolving geo-political developments in the region, particularly in Afghanistan.

"Another productive interaction with FM @ABZayed on our bilateral cooperation. Took forward our ongoing discussions on this subject, starting in February. The strong focus on post-COVID economic recovery will remain a priority for us," he said in a tweet late on Sunday along with a picture of them holding a meeting outdoors.

According to UAE's official WAM news agency, the two leaders discussed ways to develop and enhance bilateral cooperation in all domains, in a way that will fulfil the aspirations of the leadership of India and the UAE and benefit their peoples.

Emphasising on the historic ties between the two nations, Sheikh Abdullah said that the UAE-India strategic partnership contributes to creating more opportunities for growth in commercial, economic, cultural and other fields.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show

S Jaishankar discusses bilateral ties, economic recovery post-COVID with UAE counterpart

S Jaishankar arrived in Abu Dhabi on Sunday with a focus on boosting bilateral economic cooperation. His visit to the United Arab Emirates comes amid evolving geo-political developments in the region, particularly in Afghanistan.

Source: Reuters

Related stories